Flurbiprofen Sodium
NDC Package 60758-910-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Flurbiprofen Sodium is a medication used before certain types of eye surgery (such as cataract removal). Marketed by Pacific Pharma, Inc., this product is identified by NDC 60758-910 and is authorized under FDA application NDA019404.

Identification & Billing

NDC Package Code
60758-910-03
Package Description
1 BOTTLE, DROPPER in 1 CARTON / 2.5 mL in 1 BOTTLE, DROPPER
Product Code
60758-910
11-Digit Billing Format
60758091003
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Flurbiprofen Sodium
Dosage Form
-
Usage Information
This medication is used before certain types of eye surgery (such as cataract removal). It prevents the pupil of the eye from narrowing. This effect makes it easier for the doctor to examine the inside of the eye, to remove the cataract, and to replace it with a new lens. Flurbiprofen belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs).

Regulatory & Marketing

Labeler Name
Pacific Pharma, Inc.
FDA Application #
NDA019404
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
05-29-1997
End Marketing Date
09-21-2017
Listing Expiration
09-21-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60758-910-03 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 2.5 ml in 1 bottle, dropper of Flurbiprofen Sodium, labeled by Pacific Pharma, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pacific Pharma, Inc. on May 29, 1997. The current certification is valid through September 21, 2017.

What are the primary indications for this medication?

This medication is used before certain types of eye surgery (such as cataract removal). It prevents the pupil of the eye from narrowing. This effect makes it easier for the doctor to examine the inside of the eye, to remove the cataract, and to replace it with a new lens. Flurbiprofen belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs).

How is this Pacific Pharma, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60758091003. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
60758-910-03
11-Digit CMS (5-4-2)
60758-0910-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.